ALTERED HLA EXPRESSION BY METASTATIC CERVICAL-CARCINOMA CELLS AS A FACTOR IN IMPAIRED IMMUNE SURVEILLANCE

被引:44
作者
HILDERS, CGJM
MUNOZ, IM
NOOYEN, Y
FLEUREN, GJ
机构
[1] Department of Pathology, University of Leiden
关键词
D O I
10.1006/gyno.1995.1156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The altered expression of histocompatibility leukocyte antigens (HLA) in the development to cervical carcinoma suggests that tumor progression may be related to impaired recognition by host immune defense mechanisms. To investigate whether this phenomenon plays a role in the process of metastasis of cervical cancer, we analyzed and compared the HLA expression with the number of infiltrating immune cells in primary cervical carcinoma and related autologous metastases (n = 30) by staining serial paraffin and corresponding frozen sections with a panel of monoclonal antibodies. In 60% of the cervical metastases, compared to 21% of the primary tumors, a downregulation of monomorphic HLA class I antigens was observed, with frequent allele-specific alterations. In 50% the HLA class II expression was slightly increased on the metastatic tumor cells in comparison to the primary tumor. In addition, variability of alterations in HLA expression was observed between different metastases in the same patient. A minor infiltration of immune cells was present in cervical metastases compared to the primary tumors, especially in the HLA class I-downregulated metastases. Furthermore, loss of HLA class I expression on the metastatic tumor cells resulted in a significant decrease of tumor-infiltrating CD8(+) T lymphocytes. These findings suggest that in cervical carcinoma loss of HLA class I expression plays a decisive role in the escape from immune surveillance leading to a greater metastatic potential of tumor cells. (C) 1995 Academic Press, Inc.
引用
收藏
页码:366 / 375
页数:10
相关论文
共 43 条
[31]   KP1 - A NEW MONOCLONAL-ANTIBODY THAT DETECTS A MONOCYTE MACROPHAGE ASSOCIATED ANTIGEN IN ROUTINELY PROCESSED TISSUE-SECTIONS [J].
PULFORD, KAF ;
RIGNEY, EM ;
MICKLEM, KJ ;
JONES, M ;
STROSS, WP ;
GATTER, KC ;
MASON, DY .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (04) :414-421
[32]   ESTABLISHMENT IN MONOLAYER-CULTURE AND CHARACTERIZATION OF 4 HUMAN-MELANOMA CELL-LINES [J].
ROFSTAD, EK ;
WAHL, A ;
HYSTAD, ME ;
NESLAND, JM ;
STOKKE, T .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1991, 60 (03) :189-197
[33]  
RUITER DJ, 1982, J IMMUNOL, V129, P2808
[34]   PHENOTYPIC-EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS IN HUMAN PRIMARY TUMORS AND METASTASES [J].
RUIZCABELLO, F ;
NEVOT, MAL ;
GUTIERREZ, J ;
OLIVA, MR ;
ROMERO, C ;
FERRON, A ;
ESTEBAN, F ;
HUELIN, C ;
PIRIS, MA ;
RIVAS, C ;
GARRIDO, F .
CLINICAL & EXPERIMENTAL METASTASIS, 1989, 7 (02) :213-226
[35]  
SMITH SH, 1986, IMMUNOLOGY, V58, P63
[36]  
STAM NJ, 1989, INT IMMUNOL, V2, P113
[37]   EXPRESSION OF HLA-DR ANTIGENS IN NASOPHARYNGEAL CARCINOMA - AN IMMUNOHISTOLOGICAL ANALYSIS OF THE TUMOR-CELLS AND INFILTRATING LYMPHOCYTES [J].
THOMAS, JA ;
ILIESCU, V ;
CRAWFORD, DH ;
ELLOUZ, R ;
CAMMOUN, M ;
DETHE, G .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (06) :813-819
[38]   IMMUNOHISTOCHEMICAL DETECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND QUANTITATIVE-ANALYSIS OF TUMOR-INFILTRATING MONONUCLEAR-CELLS IN RENAL-CELL CANCER [J].
TOMITA, Y ;
NISHIYAMA, T ;
FUJIWARA, M ;
SATO, S .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :354-359
[39]  
VANDENBERG FM, 1993, AM J PATHOL, V142, P381
[40]  
VANDUINEN SG, 1988, CANCER RES, V48, P1019